Qu et al. further discovered that extracellular vesicles secreted by RCC cells deliver IncARSR, which promotes sunitinib resistance by competitively binding miR-34/miR-449, thereby enhancing AXL and c-MET expression in RCC (Qu et al., 2016). Here, AXL is linked to renal cell carcinoma.